Calanna S, Christensen M, Holst JJ, Laferrere B, Gluud LL, Vilsboll T, et al
ArticlePubMed REFERENCES Figure Fig
The testing is exhaustive, repeated, and documented
Other GI monitored (diarrhoea, reflux, dyspepsia) Beyond nausea, vomiting, and constipation, the clinical trials of retatrutide also monitored a range of other gastrointestinal (GI) side effects
This incredible breakthrough medical advance has helped many people to lose weight, control their appetite and cravings, and reduce many other health risks associated with being overweight
For instance, the receptors of the TGF- superfamily are able to activate either SMAD3 or STAT3 signaling in a context-dependent manner [123]